導師介紹 | ||
導師姓名 | 徐丁 |
|
導師性別 | 男 | |
職務職稱 | 副主任醫師 | |
所在院系 | 上海交通大學醫學院 | |
一級學科 | 臨床醫學 | |
二級學科 | 外科學 | |
研究方向 | 前列腺疾病，膀胱腫瘤 | |
聯系電話 | 13774445969 | |
電子郵箱 | xuding@xinhuamed.com.cn | |
個人簡介 | ||
2018-2019年前往德國Diakonie Klinikum 學習機器人手術及盆底手術，擅長泌尿系腫瘤，特別是膀胱癌、輸尿管癌、腎盂癌的全程管理與微創治療；擅長前列腺增生、慢性前列腺炎、尿失禁、尿頻尿急排尿困難等各類排尿障礙疾病的診治。主持國家自然科學基金1項，發表SCI論文十余篇。 | ||
學習與工作經歷 | ||
2005-09 至 2013-06, 上海交通大學醫學院, 臨床醫學, 博士 2013-07 至 2017-06, 上海交通大學醫學院附屬新華醫院, 泌尿外科, 醫師 2017-07 至 2021-12, 上海交通大學醫學院附屬新華醫院, 泌尿外科, 主治醫師 2022-01 至 今, 上海交通大學醫學院附屬新華醫院, 泌尿外科, 副主任醫師 | ||
科研工作與成果 | ||
主持國家自然科學基金青年項目1項，曾入選上海市科委,青年科技英才揚帆計劃 以第一作者/共同第一作者及通訊作者/共同通訊作者發表SCI論文如下： 1.Huangqi Duan, Weimin Xia, Ding Xu, et al. Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment. Front Oncol. 2022; 12: 927410.（共同通訊作者） 2.Qifeng Cao，Yu Wu，Wenbin Guan，et al. Diagnosis of Chronic Prostatitis by Noninvasive Methods in Elderly Patients with Benign Prostatic Hyperplasia in China. Andrologia. 2021; 53(6): e14055.（通訊作者） 3.Ding Xu, Zhongqing Yang, Jun Qi, et al. Early urinary continence recovery following retzius?sparing robotic?assistant radical prostatectomy with suprapubic catheter: a short?term follow?up outcome. World J Urol. 2021; 39(9):3251-3257. 4.Xiaoqiang Qian, Zhengqin Gu, Wenbin Guan, et al. Resveratrol could attenuate prostatic inflammation in rats with Oestradiol-induced chronic prostatitis. Andrologia. 2021; 53(4): e14004.（通訊作者） 5.Ding Xu, Xiaoling Lin, Xiaoqiang Qian, et al. SNPs of Metabolic Syndrome are Associated with Benign Prostatic Hyperplasia Development and Progression in Chinese Population. Current Bioinformatics. 2021; 16 (7): 901-908. 6.Lin Zhang, Yanyuan Wu, Ke Xu, et al. Compare the Clinical Application of Ureteroscopic Occluder and Stone Retrieval Basket During Holmium Laser Treatment for Upper Ureteral Calculi. Urol J. 2020; 17(5): 469-473.（共同通訊作者） 7.Yu Wu, Ding Xu, Haibo Shen, et al. The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a crosssectional study. Aging Male. 2020; 23(5): 841-846. （共同第一作者） 8.Xujun Sheng, Ding Xu, Yu Wu, et al. The risk factors of Urethrocutaneous fistula after hypospadias surgery in the youth population. BMC Urology. 2018;18(1): 64 （共同第一作者） 9.Ding Xu, Yu Wu, Haibo Shen, et al. High serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China. Aging Male. 2020; 23 (1): 1-6. 10.Qian X, Xu D, Liu H, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. Aging Male. 2017. 20(4): 250~256（共同第一作者） 11.Ding Xu, Jie Ding, Yunkai Zhu, et al. The new insight of prostate-specific antigen reduction during finasteride therapy in aging men. Aging Clin Exp Res. 2016; 28(6): 1237~1241. 12.Ding Jie, Ding Xu, Qifeng Cao, et al. Comparing theThe Risk Factors of Urethrocutaneous Fistula after Hypospadias Surgery in the youth population Efficacy of a Multimodular Flexible Ureteroscope With Its Conventional Counterpart in the Management of Renal Stones. Urology. 2015; 86(2): 224-229. (共同第一作者) 13.Jie Ding, Ding Xu, Chunwu Pan, et al. Current animal models of bladder cancer: Awareness of translatability (Review). Exp Ther Med. 2014; 8(3): 691–699. (共同第一作者) 14.Ding Xu, Yongjiang Yu, Yunkai Zhu, et al. A New Model Consists of Intravesical Prostatic Protrusion, Prostate Volume and Serum Prostatic-Specific Antigen in the Evaluation of Prostate Cancer, Pathol Oncol Res. 2014(20): 439-443. | ||
社會學術團體兼職 | ||
上海市醫學會泌尿外科分會尿控與整形學組組員 上海市排尿與盆底會診中心 會診專家 美國心臟病協會（AHA）基礎生命支持及高級心血管生命支持 導師 | ||
主要研究方向 | ||
前列腺增生，慢性前列腺炎，膀胱腫瘤 | ||
近3年指導研究生的就業情況 | ||
無 | ||
徐丁
